Welcome to our dedicated page for Inogen SEC filings (Ticker: INGN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Inogen Inc (INGN) SEC filings page on Stock Titan brings together the company’s regulatory disclosures as a Nasdaq-listed medical technology issuer. Inogen files annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K, along with other required documents, providing detailed insight into its respiratory care business for the homecare setting.
In its periodic reports, Inogen presents financial statements and operating data covering sales and rental revenue, gross profit, operating expenses such as research and development, sales and marketing, and general and administrative costs, as well as net income or loss, cash flows, and balance sheet information. Supplemental tables may break out revenue by category, including business-to-business domestic and international sales and direct-to-consumer and rental activity, reflecting how its respiratory products reach patients and providers.
Current reports on Form 8-K document material events, such as the release of quarterly financial results and certain leadership or governance changes. For example, Inogen has used Form 8-K to furnish press releases reporting results for quarters ended March 31, June 30, and September 30, 2025, and to describe appointments and designations of executive officers.
On Stock Titan, these filings are updated as they become available from EDGAR and are paired with AI-powered summaries that explain key points in accessible language. Users can quickly see what Inogen reports about its respiratory product portfolio, revenue mix between sales and rentals, operating trends, and significant corporate developments without reading every line of each document.
Investors researching INGN can use this page to access 10-K and 10-Q filings for a structured view of Inogen’s financial condition and risk disclosures, and Form 8-K filings for timely updates on results of operations and notable corporate events, all supported by AI-generated highlights.